Protection and waning of Natural and Hybrid Immunity to SARS CoV 2 Isra Zaman17 Jun 2022 12:31 PM ISTAmong persons who had been previously infected with SARS-CoV-2, protection against reinfection decreased as the time increased since the last...
CDSCO panel recommends market nod for Serum Institute qHPV vaccine against cervical cancer Ruchika Sharma16 Jun 2022 1:45 PM ISTIn the application, Singh is learnt to have stated that qHPV vaccine CERVAVAC has demonstrated robust antibody response that is nearly 1,000 times...
Bharat Biotech Covaxin booster dose broadens immunity against Delta, Omicron variants: ICMR study Ruchika Sharma15 Jun 2022 4:15 PM ISTNew Delhi: The administration of Covaxin as a booster dose enhances vaccine effectiveness against COVID-19's Delta variant and gives protection...
SEC to review Serum Institute qHPV vaccine trial data today Ruchika Sharma15 Jun 2022 11:20 AM ISTNew Delhi: The first indigenously developed quadrivalent human papillomavirus (qHPV) vaccine against cervical cancer by the Serum Institute of India...
Upgraded version of COVID booster shot has potential against main variants: Sanofi Ruchika Sharma13 Jun 2022 3:02 PM ISTParis: French drugmaker Sanofi said on Monday an upgraded version of the COVID-19 vaccine candidate it is developing with GSK showed potential in...
Pfizer-BioNTech COVID vaccines effective, safe for children aged 6 months to 4 years: USFDA staff Ruchika Sharma13 Jun 2022 1:45 PM ISTAn early analysis of data from Pfizer-BioNTech's vaccine based on 10 symptomatic COVID-19 cases identified when the Omicron coronavirus variant was...
GSK closer to cracking elusive vaccine for common respiratory virus Ruchika Sharma12 Jun 2022 11:00 AM ISTThe latest GSK trial is the first to show statistically significant efficacy for RSV in adults aged 60 years and older, the British drugmaker said of...
WHO prequalifies Sinovac Polio vaccine Ruchika Sharma12 Jun 2022 10:00 AM ISTBeijing: SINOVAC Biotech Ltd. has announced that the company has received the World Health Organization (WHO) prequalification for its Poliomyelitis...
Takeda dengue vaccine TAK-003 provides continued protection against dengue fever through 4.5 years in trial Roshni Dhar11 Jun 2022 5:06 PM ISTTakeda has announced that its dengue vaccine candidate, TAK-003, prevented 84% of hospitalized dengue cases and 61% of symptomatic cases, with no...
Moderna coronavirus vaccine effective for kids under five years: USFDA Ruchika Sharma11 Jun 2022 2:15 PM ISTEven though Moderna's vaccine has proven less effective against the Omicron variant, it remains very good at protecting against severe cases of the...
Serum Institute seeks DCGI nod to manufacture qHPV vaccine Cervavac against cervical cancer Ruchika Sharma9 Jun 2022 12:39 PM IST"This will fulfill the dream of our hon'ble Prime Minister Narendra Modi 'VOCAL FOR LOCAL' and 'MAKING IN INDIA FOR THE WORLD' and will ensure...
Novavax COVID shot gets USFDA Advisory Committee recommendation for emergency use nod for 18 years and older Ruchika Sharma8 Jun 2022 12:14 PM ISTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease.
